PULMONX CORPORATION Accrued Liabilities, Current
PULMONX CORPORATION (LUNG) had Accrued Liabilities, Current of $14.07 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-04
- 2026-06-30: Accrued Liabilities, Current $14.07M.
- 2026-03-31: Accrued Liabilities, Current $13.73M.
- 2025-12-31: Accrued Liabilities, Current $14.56M.
- 2025-09-30: Accrued Liabilities, Current $14.94M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $14.07M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $13.73M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $14.56M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $14.94M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $14.39M 10-Q · filed 2025-08-01 | |
| 2025-03-31 | $11.55M 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $16.47M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $12.78M 10-Q · filed 2024-11-01 | |
| 2024-06-30 | $11.78M 10-Q · filed 2024-08-02 | |
| 2024-03-31 | $10.07M 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $16.23M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $13.68M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $13.56M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $10.63M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $13.28M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $10.74M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $11.73M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $10.87M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $13.37M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $12.37M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $11.55M 10-Q · filed 2021-11-09 | $10.50M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $10.22M 10-Q · filed 2021-11-09 | $9.76M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $8.65M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $8.84M 10-Q · filed 2020-11-13 | |
| 2019-12-31 | $9.46M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |